Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01039493
Recruitment Status : Completed
First Posted : December 25, 2009
Last Update Posted : October 2, 2015
Information provided by (Responsible Party):
University of Wisconsin, Madison

Brief Summary:
The objective of this study is to establish patient preferences in regards to common complications of cervical cancer treatments, and to compare these preferences to those of medical providers who care for cervical cancer patients. These preferences will be determined via a interview using the Standard Gamble, which is a well-recognized method for establishing utilities.

Condition or disease
Cervical Cancer

Study Type : Observational
Actual Enrollment : 40 participants
Time Perspective: Cross-Sectional
Official Title: Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
Study Start Date : February 2010
Actual Primary Completion Date : August 2010
Actual Study Completion Date : August 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cervical Cancer


Primary Outcome Measures :
  1. Utilities of complications associated with cervical cancer treatment. [ Time Frame: At time of interview ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 61 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patient Population: Patients ≥18 and <61 years old who were diagnosed with early cervical cancer (stages I and II) at least 3 years prior to the interview. We cannot limit our population to stage IB2 patients and meet our accrual goals due to the rarity of the disease. Patients with stages I and II cervical cancer are included because they have the potential to be exposed to the same treatment complications as patients with stage IB2 disease. Patients of all health statuses will be accepted.

Provider Population: Providers who care for patients with cervical cancer at the University of Wisconsin, including: gynecologic oncologists, radiation oncologists, physician's assistants and nurses. Providers must be ≥18 and <61 years old in any health status.


Inclusion Criteria:

  • A subject has to have been diagnosed with early cervical cancer (Stage I or II) within the last 3 years and/or take care of patients with cervical cancer and identify her or himself as one of the following: gynecologic oncologist, radiation oncologist, physician's assistant or nurse.
  • Subjects must be ≥18 and <61 years old.

Exclusion Criteria:

  • Subjects who are unable to read and speak English proficiently will be excluded. Proficiency will be assessed by the investigator enrolling patients.
  • Subjects who do not have capacity to consent will not be included in this study.
  • Subjects may not be investigators on this study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01039493

United States, Wisconsin
University of Wisconsin-Madison
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Principal Investigator: Ellen M Hartenbach, MD University of Wisconsin, Madison

Responsible Party: University of Wisconsin, Madison Identifier: NCT01039493     History of Changes
Other Study ID Numbers: M-2009-1240
OS09708 ( Other Identifier: UW Carbone Cancer Center )
First Posted: December 25, 2009    Key Record Dates
Last Update Posted: October 2, 2015
Last Verified: September 2015

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female